Caretrust REIT, Inc. current report, 13 May 2016

Business Context and Reporting Period

CareTrust REIT, Inc. filed a Form 8-K Current Report on May 13, 2016. The filing discloses the entry into an equity distribution agreement to facilitate an "at-the-market" offering program for the sale of common stock.

Key Financial Metrics

This filing does not report operational financial metrics such as revenue, profit, cash flow, margins, or debt levels. The primary financial figure disclosed is the aggregate offering price of up to $125,000,000 for shares of common stock under the new distribution agreement.

Material Changes

The material change reported is the execution of an Equity Distribution Agreement with multiple sales agents, including BMO Capital Markets Corp., Barclays Capital Inc., Canaccord Genuity Inc., KeyBanc Capital Markets Inc., Raymond James & Associates, Inc., and Wells Fargo Securities, LLC. This agreement authorizes the sale of shares from time to time through ordinary brokerage transactions on the NASDAQ Global Select Market.

Guidance, Outlook, and Use of Proceeds

Management intends to contribute the net proceeds from the share sales to the Operating Partnership. The proceeds are designated for general corporate purposes, which may include future acquisitions, debt repayment, and working capital. The company may temporarily invest net proceeds in interest-bearing short-term investments consistent with its REIT qualification. The offering will terminate upon the sale of the maximum aggregate amount or earlier termination of the agreement.

Investor Verification Checklist

  • Verify the total number of shares sold and actual proceeds generated under the $125 million program in subsequent filings.
  • Review the full text of the Equity Distribution Agreement (Exhibit 1.1) for specific commission rates and termination clauses.
  • Monitor future 8-K filings to confirm how proceeds are allocated between acquisitions, debt repayment, and working capital.
  • Check the company's shelf registration statement (Form S-3, File No. 333-208925) for any additional restrictions on share issuance.